CB
SUPN icon

Commerce Bank’s Supernus Pharmaceuticals SUPN Stock Holding History

Commerce Bank’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$588K Hold
12,639
– – ﹤0.01% 913
2026
Q1 		$653K Sell
12,639
-692
-5% -$35.2K ﹤0.01% 849
2025
Q4 		$663K Sell
13,331
-819
-6% -$39.8K ﹤0.01% 788
2025
Q3 		$676K Sell
14,150
-975
-6% -$39.3K ﹤0.01% 774
2025
Q2 		$477K Buy
15,125
+100
+0.7% +$3.21K ﹤0.01% 875
2025
Q1 		$492K Buy
15,025
+1,720
+13% +$60.9K ﹤0.01% 850
2024
Q4 		$481K Sell
13,305
-225
-2% -$7.92K ﹤0.01% 873
2024
Q3 		$422K Sell
13,530
-305
-2% -$9.52K ﹤0.01% 949
2024
Q2 		$370K Hold
13,835
– – ﹤0.01% 955
2024
Q1 		$472K Sell
13,835
-510
-4% -$15.2K ﹤0.01% 881
2023
Q4 		$415K Sell
14,345
-172
-1% -$4.56K ﹤0.01% 909
2023
Q3 		$400K Sell
14,517
-208
-1% -$6.33K ﹤0.01% 857
2023
Q2 		$443K Sell
14,725
-175
-1% -$6.12K ﹤0.01% 840
2023
Q1 		$540K Sell
14,900
-575
-4% -$22.1K ﹤0.01% 774
2022
Q4 		$552K Sell
15,475
-4,235
-21% -$147K ﹤0.01% 751
2022
Q3 		$667K Hold
19,710
– – 0.01% 659
2022
Q2 		$570K Hold
19,710
– – ﹤0.01% 735
2022
Q1 		$637K Sell
19,710
-815
-4% -$25K ﹤0.01% 750
2021
Q4 		$598K Buy
20,525
+3,030
+17% +$91.9K ﹤0.01% 786
2021
Q3 		$466K Sell
17,495
-1,320
-7% -$35.4K ﹤0.01% 858
2021
Q2 		$579K Sell
18,815
-60
-0.3% -$1.84K ﹤0.01% 783
2021
Q1 		$494K Buy
18,875
+5,520
+41% +$154K ﹤0.01% 822
2020
Q4 		$336K Sell
13,355
-180
-1% -$3.87K ﹤0.01% 912
2020
Q3 		$282K Buy
13,535
+4,045
+43% +$91.8K ﹤0.01% 881
2020
Q2 		$225K Buy
+9,490
New +$210K ﹤0.01% 919

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Commerce Bank's SUPN Position: Q2 2026 in Review

Commerce Bank held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 12,639 shares worth $588K. The position accounts for ﹤0.01% of the portfolio, ranked #913.

Commerce Bank first reported a position in SUPN in Q2 2020 and has held it in 25 quarters since. The position peaked at $676K in Q3 2025. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Commerce Bank held 12,639 shares of Supernus Pharmaceuticals worth $588K as of Q2 2026.
  • Commerce Bank left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of Commerce Bank's portfolio in Q2 2026, its #913 holding.
  • Commerce Bank first reported a position in Supernus Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
  • Commerce Bank's Supernus Pharmaceuticals position peaked at $676K in Q3 2025.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.